Home About ATSDR Press Room A-Z Index Glossary Employment Training Contact Us CDC  
ATSDR/DHHS Agency for Toxic Substances and Disease Registry Agency for Toxic Substances and Disease Registry Department of Health and Human Services ATSDR en Español

Search:

Section Contents
 
References
 
Case Contents
 
Table of Contents
Cover Page
How to Use the Course
Initial Check
What is Asbestos
Where Found
Exposure
Who Is At Risk?
U.S. Standards
Biological Fate
Pathogenic Changes
Respiratory Conditions
Other Conditions
Clinical Evaluation
Diagnostic Tests
Treatment
Patients' Instructions
More Information
Posttest
 
Case Studies (CSEM)
 
CSEM Home
Continuing Education
Online Registration
 
Related Documents
 
Exposure Registry
Exposure Review
Naturally Ocurring
Public Health Statement
Toxicological Profile
ToxFAQs™
 
ATSDR Resources
 
Case Studies (CSEM)
Exposure Pathways
GATHER (GIS)
Health Assessments
Health Statements
Interaction Profiles
Interactive Learning
Managing Incidents
Medical Guidelines
Minimal Risk Levels
Priority List
ToxFAQs™
ToxFAQs™ CABS
Toxicological Profiles
Toxicology Curriculum
 
External Resources
 
CDC
eLCOSH
EPA
Healthfinder®
Medline Plus
NCEH
NIEHS
NIOSH
OSHA
 

Agency for Toxic Substances and Disease Registry
Case Studies in Environmental Medicine (CSEM) 

Asbestos Toxicity
Literature Cited


References

  1. Agency for Toxic Substances and Disease Registry. 2001. Toxicological profile for asbestos. Atlanta: US Department of Health and Human Services.
  2. Agency for Toxic Substances and Disease Registry. 2001a. Chemical-specific health consultation: tremolite asbestos and other related types of asbestos. Atlanta: US Department of Health and Human Services.
  3. American Thoracic Society. 2004. Diagnosis and initial management of nonmalignant diseases related to asbestos. American Journal of Respiratory and Critical Care Medicine 170:691-715.
  4. Balmes J. 2004. Occupational lung diseases. Current Occupational and Environmental Medicine. J. LaDou, editor. New York: Lange Medical Books/McGraw-Hill, P. 338-9.
  5. British Thoracic Society Standards of Care Committee. 2001. Statement on malignant mesothelioma in the United Kingdom. Thorax 56:250-65.
  6. Broaddus VC. 2001. Apoptosis and asbestos-induced disease: is there a connection? Laboratory and Clinical Medicine 137(5):314-5.
  7. Chapman S, Cookson WOC, Musk AW, Lee YCG. 2003. Benign asbestos pleural diseases. Current Opinion in Pulmonary Medicine 9:266-71.
  8. Dodson RF, Atkinson MA, Levin JL. 2003. Asbestos fiber length as related to potential pathogenicity: a critical review. American Journal of Industrial Medicine 44(3):291-297.
  9. Environmental Protection Agency. 2000 http://www.epa.gov/asbestos/pubs/verm.html
  10. Griffith H, Malony NC. 2003. Does asbestos cause laryngeal cancer? Clinical Otolaryngology 28: 177-82.
  11. Hasanoglu H, Gokirmak M, Baysal T, Yildirim Z, Koksal N, Onal Y. 2003. Environmental exposure to asbestos in Eastern Turkey. Archives of Environmental Health 58(3):144-50.
  12. Henderson DW, Rodelsperger K, Woitowitz HJ, Leigh J. 2004. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004. Pathology 36(6):517-550.
  13. Hillerdal G. 1999. Mesothelioma: cases associated with non-occupational and low dose exposures. Occupational Environmental Medicine 56:505-13.
  14. Holland JP, Smith DD. 2003. Asbestos. Occupational, industrial, and environmental toxicology. In: MI Greenberg, Hamilton RJ, Phillips SD, McClusky GJ, editors. Philadelphia: Mosby, p. 650-69.
  15. Joubert L, Seidman H, Selikoff IJ. 1991. Mortality experience of family contacts of asbestos factory workers. Annals of the New York Academy of Sciences. 643:416-418.
  16. Kamp D, Weitzman SA. 1999. The molecular basis of asbestos induced lung injury. Thorax 54: 638-52.
  17. Kamp DW, Weitzman SA. 1997. Asbestosis: clinical spectrum and pathogenic mechanisms. Proceedings of the Society of Experimental Biology and Medicine 14(1):12-26.
  18. Kamp DW, Panduri V, Weitzman SA, Chandel N. 2002. Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals. Molecular and Cellular Biochemistry 234/235:153-60.
  19. Khan et al. 2004. Asbestos-related disease. URL: http://www.emedicine.com/radio/topic53.htm.
  20. Lee PN. 2001. Relation between exposure to asbestos and smoking jointly and the risk of lung cancer. Occupational and Environmental Medicine 58(3):145-153.
  21. Lee DH, Selikoff IJ. 1979. Historical background to the asbestos problem. Environmental Research 18(2):300-314.
  22. Lee RJ, Van Orden DR, Corn M, Crump KS. 1992. Exposure to airborne asbestos in buildings. Regulatory Toxicology and Pharmacology 16(1):93-107.
  23. Lee YC, Light RW, Musk AW. 2000. Management of malignant pleural mesothelioma: a critical review. Current Opinion in Pulmonary Medicine 6(4):267-274.
  24. Luo S, Liu X, Mu S, Tsai SP, Wen CP. 2003. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and environmental data. Occupational Environmental Medicine 60:35-42.
  25. Minna, JD. 2005. Neoplasms of the lung. In: Harrison’s Principles of Internal Medicine, 16th edition. TR Harrison et al., editors. USA: McGraw-Hill, 552-568.
  26. Muravov OI, Kaye WE, Lewin M, Berkowitz Z, Lybarger JA, Campolucci SS, Parker JE. 2005. The usefulness of computed tomography in detecting asbestos-related pleural abnormalities in people who had indeterminate chest radiographs: the Libby, MT, experience. International Journal of Hygiene and Environmental Health. 208(1-2):87-99.
  27. National Academy of Sciences. 2006. Asbestos: Selected Cancers. Washington, DC: The National Academies Press, ps. 394.
  28. National Institutes of Health. Testimony of Kathleen M. Rest, Ph.D, M.P.A, on Workplace Exposure to Asbestos before the Committee on Health, Education, Labor and Pensions, United States Senate, July 31, 2001.
  29. Nicholson WJ, Perkel G, Selikoff IJ. 1982. Occupational exposure to asbestos: population at risk and projected mortality—1980-2030. American Journal of Industrial Medicine 3(3):259-311.
  30. Pan SY, Ugnat AM, Mao Y; The Canadian Cancer Registries Epidemiology Research Group. 2005. Occupational risk factors for brain cancer in Canada. Journal of Occupational and Environmental Medicine 47(7):704-717.
  31. Peacock C, Copley SJ, Hansell DM. 2000. Asbestos-related benign pleural disease. Clinical Radiology 55(6):422-432.
  32. Rockoff SC, Rubin LJ. 2002. Special report: asbestos-induced pleural plaques—a disease process associated with ventilatory impairment and respiratory symptoms. Clinical Pulmonary Medicine 9(2):113-24.
  33. Rosenberg DM. 1997. Asbestos-related disorders. A realistic perspective. Chest. 111(5):1424-1426.
  34. Ross RM. 2003. The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest 124(3):1120-1128.
  35. Seidman H, Selikoff, IJ. 1990. Decline in death rates among asbestos insulation workers 1967-1986 associated with diminution of work exposure to asbestos. Annals of the New York Academy of Sciences 609: 300-17, 317-8.
  36. Stathopoulos GT, Karamessini MT, Sotiriadi AE, Pastromas VG. 2005. Rounded atelectasis of the lung. American Journal of Industrial Medicine 44(3):291-297.
  37. Weill H, Hughes JM, Churg AM. 2004. Changing trends in US mesothelioma incidence. Occupational Environmental Medicine 61:438-41.
  38. Weiss W. 1999. Asbestosis: a marker for the increased risk of lung cancer among workers exposed to asbestos. Chest 115(2):536-4.
  39. Yano E, Wang Z, Wang X, Wang M, Lan Y. 2001. Cancer mortality among workers exposed to amphibole-free chrysotile asbestos. American Journal of Epidemiology 154(6):538-43.

Previous Section

Revised 2007-04-19.